MLTX
MoonLake Immunotherapeutics
NASDAQ · CHHealthcareBiotechnology
$19.05-3.20%
Price as of Jul 20, 2026
MLTX valuation
MoonLake Immunotherapeutics valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.52x
- Price / sales
- —
- Price / cash flow
- -6.26x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- —
- EV / EBITDA
- -4.66x
- EV / EBIT
- -4.28x
- Market cap
- $1.4B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.